Genomic Solutions and ProteoMetrics sign tools pact

29 July 2001

Genomic Solutions, a supplier of automated solutions for genomic andproteomic research, is to jointly develop proteomics software with ProteoMetrics, a New York, USA-based firm. The two companies said they will create a bioinformatic product integrating Genomic Solutions' Investigator Protein Warehouse data integration software with ProteoMetrics' RADARS system for mass spectrometry data analysis. Genomic Solutions will also distribute ProteoMetrics' existing software products, such as Knexus and Profound. It also has a first right of refusal to acquire ProteoMetrics.

Jeffrey Williams, Genomic Solutions' chief executive, said that the relationship with ProteoMetrics will strengthen his firm's presence in bioinformatics and proteomics software in the life sciences marketplace. David Miller, the former firm's global product manager for proteomics, added that "the combined strengths of the two companies will bolster each of our leadership positions as providers of proteomic research tools."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight